NEW FACTORS OF FIBROPLAST GROWTH

摘要

FIELD: medicine. ^ SUBSTANCE: invention concerns application of polypeptide FGF-9 or its biologically active fragment to produce medical product for multiple sclerosis treatment. Polypeptide can be 94-95% identical to sequence from amino acid 1 to amino acid 208 of human FGF-9, presented on fig. 3 (SEQ ID NO: 5). ^ EFFECT: invention stimulates myelination, proliferation and persistency of oligodendrocyte neurons, improves nervous regeneration. ^ 6 cl, 9 dwg, 3 tbl, 3 ex